Verified Nov 2026
Other
·

Jersey City, New Jersey
·
Since
Organon is a global healthcare company headquartered in Jersey City, New Jersey, established in June 2021 as a spin-off from Merck & Co. With 10,000–50,000 employees and estimated revenue of $5–10 billion, it operates in approximately 140 markets. The company manufactures over 60 medicines and products across reproductive health, psychiatry, hormone replacement therapy, and anesthesia. In September 2026, the FDA accepted for review a supplemental application for MIUDELLA, a hormone-free intrauterine device Organon licensed from Sebela Pharmaceuticals.
Organon at a glance
Revenue
$5-10B
Est. band
Employees
10,000-50,000
Headquarters
Jersey City, New Jersey
Certifications
ISO 9001
Import activity
157
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
157
Named foreign suppliers
15
Top origins
Netherlands · Belgium · Mexico · United Kingdom

Shared foreign counterparties do not establish that these companies buy from Organon.
What this tells a buyer
Customs records document 157 shipments across multiple origins including the Netherlands, Belgium, Mexico, United Kingdom, Singapore, Italy, and Hong Kong, with significant inbound flows from affiliated entities in Switzerland and the United Kingdom.
The company holds ISO 9001 certification and operates six manufacturing facilities to produce prescription medicines, biosimilars, and medical devices across multiple therapeutic areas.
In April 2026, Sun Pharma signed a definitive agreement to acquire Organon, marking a significant transition in company ownership.
Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026
STABILITY SIGNALS
Established & active
157 US import shipments on record.
Holds ISO 9001 certification(s) per public sources.
Overview
Organon is a global healthcare company headquartered in Jersey City, New Jersey, established in June 2021 as a spin-off from Merck & Co. With 10,000–50,000 employees and estimated revenue of $5–10 billion, it operates in approximately 140 markets. The company manufactures over 60 medicines and products across reproductive health, psychiatry, hormone replacement therapy, and anesthesia. In September 2026, the FDA accepted for review a supplemental application for MIUDELLA, a hormone-free intrauterine device Organon licensed from Sebela Pharmaceuticals.
At a glance
Attribute | Detail |
|---|---|
Headquarters | Jersey City, New Jersey |
Employees | 10,000-50,000 |
Revenue | $5-10B (estimated) |
Certifications | ISO 9001 |
What Organon makes
The company holds ISO 9001 certification and operates six manufacturing facilities to produce prescription medicines, biosimilars, and medical devices across multiple therapeutic areas.
Products and capabilities described on the company's own site include Assembly (source: organon.com).
Certifications
Organon is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 9001 — organon.com
Trade and customs footprint
Customs records document 157 shipments across multiple origins including the Netherlands, Belgium, Mexico, United Kingdom, Singapore, Italy, and Hong Kong, with significant inbound flows from affiliated entities in Switzerland and the United Kingdom. US customs bill-of-lading records list 157 inbound shipments across 15 foreign suppliers, with top origins including Netherlands · Belgium · Mexico · United Kingdom.
Latest developments
2026-09-14 — Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for MIUDELLA®, a Hormone-Free Intrauterine Device | Organon (organon.com)
2026-06-22 — Organon Completes Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device | Organon (organon.com)
2026-05-21 — Hanmi Pharmaceutical Partners with Organon to Export Combination Drugs to Southeast Asia - Seoul Economic Daily (sedaily.com)
2026-04-30 — Organon Reports Results for the First Quarter Ended March 31, 2026 | Organon (organon.com)
2026-04-26 — Sun Pharma signs Definitive Agreement to Acquire Organon | Organon (organon.com)
2026-02-23 — Organon Enters into Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device | Organon (organon.com)
Company details
In April 2026, Sun Pharma signed a definitive agreement to acquire Organon, marking a significant transition in company ownership. Organon has an estimated 10,000-50,000 employees, and is headquartered in Jersey City, New Jersey. On the LightSource stability read it is rated "Established & active": 157 US import shipments on record. Holds ISO 9001 certification(s) per public sources.
Frequently asked questions
What does Organon do?
Organon is a global healthcare company headquartered in Jersey City, New Jersey, established in June 2021 as a spin-off from Merck & Co. With 10,000–50,000 employees and estimated revenue of $5–10 billion, it operates in approximately 140 markets. The company manufactures over 60 medicines and products across reproductive health, psychiatry, hormone replacement therapy, and anesthesia. In September 2026, the FDA accepted for review a supplemental application for MIUDELLA, a hormone-free intrauterine device Organon licensed from Sebela Pharmaceuticals.
Where is Organon headquartered?
Organon is headquartered in Jersey City, New Jersey (30 Hudson Street, Jersey City, New Jersey, 07302).
How big is Organon?
Organon has an estimated 10,000-50,000 employees, with revenue in the $5-10B range (estimated).
What certifications does Organon hold?
Organon lists ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.
Does Organon import from overseas suppliers?
US customs bill-of-lading records show 157 inbound shipments for Organon, with top origins including Netherlands · Belgium · Mexico · United Kingdom.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
